- TV Footage
- Financial Reports
- Newsletter Overview
- Social Media
- Media Contact
Leverkusen, July 27, 2018 – Grants4Impact (G4I), a new energizer program launched by Bayer Cares Foundation, is providing targeted support to social impact pioneers and start-ups in the fields of healthcare and nutrition. The aim of the program is to give selected change-makers around the world new opportunities to grow and transform great ideas into powerful impact solutions that help to improve the lives of millions. In batch periods of two years five carefully selected projects are being granted a total of EUR 1 million to help scale their ideas to the next level of impact. Each project receives EUR 150,000 in cash contributions as well as additional in-kind benefits (e.g. training, mentoring, coaching and PR or visibility boosts) worth EUR 50,000 in all.
“Grants4Impact is to be a kind of incubator for visionary social pioneers working on solutions to the major challenges in the healthcare and nutrition fields,” explains Thimo V. Schmitt-Lord, CEO, Bayer Foundations. “Besides gaining access to more funding, these young entrepreneurs will be gaining valuable know-how through the close cooperation with Bayer. Together we want to unleash the scale-up potential of their projects to help millions of disadvantaged people around the world enjoy a better quality of life.”
The five projects to be supported in the first round of Grants4Impact awards are SANI SOLAR, a solar-powered maintenance-free sanitation project developed in Germany and being piloted in Brazil; COOLAR, an electricity-free cooling system for drugs and food developed in Germany and being piloted in Kenya; iBreast Exam, a handheld breast cancer screening device developed in the USA and being piloted in Brazil: SafetyNet, a smart nets for selective fishery project developed in the UK and being piloted in Indonesia; and BISA M-Health, a telemed service developed in Ghana and being piloted in Senegal.
Telemed service – meet your doctor online
Millions of people in rural Africa live more than a day’s travel away from the next doctor – and thus have little or no access to basic healthcare. BISA M-Health, an “Ask Your Doctor Online” service app, gives Africans living in remote areas the chance to get medical advice from a pool of doctors. In a one-on-one smartphone chat patients can talk through their symptoms with a doctor, who then advises whether a visit to a doctor’s surgery or hospital is necessary. Through the support of Grants4Impact, this telemed service, which was originally developed and implemented in English-speaking Ghana by Raindolf Owusu, is now being extended to French-speaking Senegal through a new French-language version of the BISA app. The NGO partner is this project is Germany’s YOU Foundation.
All five projects from the first Grants4Impact round were nominated for the Aspirin Social Innovation Awards 2017-18. Bayer Cares Foundation presents these awards to innovative concepts that are helping to close gaps in the healthcare and nutritional fields and have the potential to create sustainable systemic changes. 33 initiatives or social pioneers have been awarded a total of EUR 235,000 since the program was introduced in 2010.
Bayer Cares Foundation
As the social impact foundation of the innovation company Bayer, the Bayer Cares Foundation sees itself as initiator, promoter and partner for innovation at the interface between academia, industry and civil society. The programs are focused on people – their commitment to societal progress, their wealth of ideas in fulfilling social challenges, and those that arise in times of emergency. The foundation’s funding activities are a central element of Bayer’s global corporate societal engagement (CSE) of around EUR 49 million annually – with the focus on promoting frontier science and social innovations connected to the UN’s Global Development Goals of Zero Hunger and Health and Well-Being.
You can find out more about the Bayer Cares Foundation at http://www.bayer-foundations.com
For more information see www.bayer.de.
Follow us on twitter: twitter.com/BayerPresse_DE
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.